2-amino-5-phosphonovalerate and fentanyl

2-amino-5-phosphonovalerate has been researched along with fentanyl in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bouairi, E; Evans, C; Gold, A; Griffioen, KJ; Huang, ZG; Mendelowitz, D; Venkatesan, P; Wang, X	1
Asouchidou, I; Asprodini, EK; Kilindris, T; Kostopoulos, G; Koukoutianou, I; Kouvaras, E; Michaloudis, D; Papatheodoropoulos, C; Vasilaki, A	1

Other Studies

2 other study(ies) available for 2-amino-5-phosphonovalerate and fentanyl

Article	Year
Fentanyl inhibits GABAergic neurotransmission to cardiac vagal neurons in the nucleus ambiguus. Brain research, 2004, May-08, Volume: 1007, Issue:1-2 Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Anesthetics, Local; Animals; Animals, Newborn; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Fentanyl; gamma-Aminobutyric Acid; Glycine Agents; Heart; In Vitro Techniques; Medulla Oblongata; Membrane Potentials; Narcotics; Neural Inhibition; Neurons; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Somatostatin; Strychnine; Synaptic Transmission; Tetrodotoxin; Vagus Nerve; Valine	2004
Fentanyl treatment reduces GABAergic inhibition in the CA1 area of the hippocampus 24 h after acute exposure to the drug. Neuropharmacology, 2008, Volume: 55, Issue:7 Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Analgesics, Opioid; Animals; Bicuculline; Electric Stimulation; Electrophysiology; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Fentanyl; GABA Antagonists; gamma-Aminobutyric Acid; Hippocampus; Hyperalgesia; Immunohistochemistry; Male; Neuronal Plasticity; Patch-Clamp Techniques; Pyramidal Cells; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, GABA-B	2008

Article

Year

Fentanyl inhibits GABAergic neurotransmission to cardiac vagal neurons in the nucleus ambiguus.

Brain research, 2004, May-08, Volume: 1007, Issue:1-2

Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Anesthetics, Local; Animals; Animals, Newborn; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Fentanyl; gamma-Aminobutyric Acid; Glycine Agents; Heart; In Vitro Techniques; Medulla Oblongata; Membrane Potentials; Narcotics; Neural Inhibition; Neurons; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Somatostatin; Strychnine; Synaptic Transmission; Tetrodotoxin; Vagus Nerve; Valine

2004

Fentanyl treatment reduces GABAergic inhibition in the CA1 area of the hippocampus 24 h after acute exposure to the drug.

Neuropharmacology, 2008, Volume: 55, Issue:7

Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Analgesics, Opioid; Animals; Bicuculline; Electric Stimulation; Electrophysiology; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Fentanyl; GABA Antagonists; gamma-Aminobutyric Acid; Hippocampus; Hyperalgesia; Immunohistochemistry; Male; Neuronal Plasticity; Patch-Clamp Techniques; Pyramidal Cells; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, GABA-B

2008